Previous 10 | Next 10 |
The ongoing ARISE-HF Phase 3 global clinical trial is evaluating the efficacy of AT-001 (caficrestat) on cardiac functional capacity in patients with diabetic cardiomyopathy (DbCM) Baseline data from ARISE-HF shows patients with DbCM exhibit reduced cardiac functional capacity resulti...
2023-09-26 13:46:32 ET Gainers: Soleno Therapeutics ( SLNO ) +446% . Femasys ( FEMY ) +271% . Immunovant ( IMVT ) +101% . Intercept Pharmaceuticals ( ICPT ) +79% . Acasti Pharma ( ACST ) +35% . Applied Therapeutics ( APLT ...
2023-09-19 13:01:28 ET Gainers: Connexa Sports Technologies ( CNXA ) +170% . Davis Commodities Limited Ordinary Shares ( DTCK ) +83% . Maplebear ( CART ) +40% . Avinger ( AVGR ) +40% . Rackspace Technology ( RXT ) +37% . Elut...
Applied Therapeutics, Inc. (NASDAQ: APLT) is one of today's top gainers. The company's shares are currently up 22.76% on the day to $2.43. Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabeti...
2023-09-06 12:53:35 ET Gainers: NeuBase Therapeutics ( NBSE ) +124% . Palisade Bio ( PALI ) +113% . Power REIT ( PW ) +45% . AeroVironment ( AVAV ) +26% . Theratechnologies ( THTX ) +27% . iCoreConnect ( ICCT ) +20% ....
2023-09-06 10:00:10 ET More on Health Care Select Sector SPDR Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR Dividend scorecard for Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare ( XLV ) ...
2023-09-06 09:17:41 ET More on Applied Therapeutics Seeking Alpha’s Quant Rating on Applied Therapeutics Historical earnings data for Applied Therapeutics Financial information for Applied Therapeutics Applied Therapeutics: Buy For Upcoming Pre-NDA Mee...
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced successful completion of...
2023-08-17 04:28:21 ET Summary Applied Therapeutics is a micro-cap with low cash balance, but has major upcoming catalysts (pre-NDA meeting for galactosemia and phase 3 results in diabetic cardiomyopathy) and a huge upside potential. Despite missing the primary endpoint in galacto...
2023-08-10 12:25:36 ET Applied Therapeutics press release ( NASDAQ: APLT ): Q2 GAAP EPS of -$0.37. Cash and cash equivalents and short-term investments totaled $35.6 million as of June 30, 2023, compared with $30.6 million at December 31, 2022. For further details se...
News, Short Squeeze, Breakout and More Instantly...
Applied Therapeutics Inc. Company Name:
APLT Stock Symbol:
NYSE Market:
Applied Therapeutics Inc. Website:
2024-07-27 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the Company was adde...
2024-06-11 10:45:04 ET Palo Alto Networks Inc (PANW) PANW is trading UP for the last 5 days, and it at trading at $313.28 with volume of 858,188 and a one day change of $4.23 (1.37%). Palo Alto Networks Inc has a 52-week low of 201.17 and a 52-week high of $380.84. The business's 50...